BYL719, a new α-specific PI3K inhibitor: Single administration and in combination with conventional chemotherapy for the treatment of osteosarcoma-Reference-Cited by-同舟云学术

BYL719, a new α-specific PI3K inhibitor: Single administration and in combination with conventional chemotherapy for the treatment of osteosarcoma

Published:2014-06-30 Issue:4 Volume:136 Page:784-796
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Gobin Bérengère¹²,Huin Marc Baud'¹²,Lamoureux François¹²,Ory Benjamin¹²,Charrier Céline¹²³,Lanel Rachel¹²,Battaglia Séverine¹²,Redini Françoise¹²³⁴,Lezot Frédéric¹²,Blanchard Frédéric¹²³,Heymann Dominique¹²³⁴

Affiliation:

1. INSERM, UMR 957; Nantes 44035 France

2. Université de Nantes; Physiopathologie de la Résorption Osseuse et Thérapie des Tumeurs Osseuses Primitives; Nantes 44035 France

3. Equipe LIGUE Nationale Contre le Cancer 2012; Nantes 44035 France

4. CHU de Nantes; Nantes 44035 France

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference50 articles.

1. Osteosarcoma (osteogenic sarcoma);Picci;Orphanet J Rare Dis,2007

2. Bone sarcomas: pathogenesis and new therapeutic approaches;Heymann;IBMS BoneKEy,2011

3. Current therapeutic strategy and novel approaches in osteosarcoma;Ando;Cancers,2013

4. Emerging drugs for high-grade osteosarcoma;Hattinger;Expert Opin Emerg Drugs,2010

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of catechin on the malignant biological behavior of gastric cancer cells through the PI3K/Akt signaling pathway;Toxicology and Applied Pharmacology;2024-09

2. TSP50 facilitates breast cancer stem cell-like properties maintenance and epithelial-mesenchymal transition via PI3K p110α mediated activation of AKT signaling pathway;Journal of Experimental & Clinical Cancer Research;2024-07-20

3. Establishment of canine mammary gland tumor cell lines harboring PI3K/Akt activation as a therapeutic target;BMC Veterinary Research;2024-05-29

4. What Do German Molecular Tumor Boards Recommend in Patients with PIK3CA-Mutated Tumors? Launch and First Results from the German Transsectoral Molecular Tumor Board Exchange Platform Deutschland;Oncology Research and Treatment;2024-05-07

5. The combination of breast cancer PDO and mini‐PDX platform for drug screening and individualized treatment;Journal of Cellular and Molecular Medicine;2024-05